Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 3 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 4 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

Sleep-disordered breathing a red flag for ischaemic stroke recurrence

15 Mar 2019

Sleep-disordered breathing (SDB) is associated with an increased risk of recurrent ischaemic stroke but not mortality, a study has shown.

The study included 842 ischaemic stroke patients (median age, 65 years; 47 percent female) from the BASIC* project. All patients underwent screening for SDB (defined as respiratory event index [REI] score ≥10) with the ApneaLink Plus device, as well as active and passive surveillance for recurrent ischaemic stroke.

Results showed that the median REI score was 14 (interquartile range, 6–26), with more than half of the population (63 percent) having SDB. SDB was associated with male sex, Mexican American ethnicity, lower educational attainment, higher body mass index, nonsmoking status, diabetes mellitus and hypertension.

Among 775 Mexican American and non-Hispanic whites with an index stroke event and complete data, 85 (11 percent) recurrent ischaemic stroke events and 104 (13 percent) deaths occurred over a median follow-up of 591 days.

In fully adjusted cause-specific proportional hazards models, REI was associated with an increased risk of recurrent ischaemic stroke (1-unit higher REI score: hazard ratio [HR], 1.02; 95 percent CI, 1.01–1.03) but not with the risk of mortality alone (HR, 1.00; 0.99–1.02).

According to researchers, SDB could not explain the previously identified higher risk of recurrent stroke in Mexican Americans vs non-Hispanic whites. Nevertheless, the present data support the need for a trial of SDB treatment for recurrent stroke prevention regardless of ethnicity.

*Brain Attack Surveillance in Corpus Christ

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 3 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 4 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.